Setting the Record Straight: Activity of Gemcitabine Monotherapy for Breast Cancer

Publisher： Karger

E-ISSN： 1423-0232|66|4|339-340

ISSN： 0030-2414

Source： Oncology, Vol.66, Iss.4, 2004-06, pp. : 339-340

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Setting the record straight

By Gordon R.C.  

The Lancet, Vol. 360, Iss. 333, 2002-08 ,pp. : 650-651

Elsevier

Access to resources Recommend Favorite

First-Line Herceptin® Monotherapy in Metastatic Breast Cancer

By  

Oncology, Vol. 61, Iss. 2, 2001-10 ,pp. : 37-42

Karger

Access to resources Recommend Favorite

The Evolving Role of Gemcitabine in the Management of Breast Cancer

By  

Oncology, Vol. 60, Iss. 3, 2001-04 ,pp. : 189-198

Karger

Access to resources Recommend Favorite

Role of Gemcitabine in the Treatment of Advanced and Metastatic Breast Cancer

By  

Oncology, Vol. 64, Iss. 3, 2003-04 ,pp. : 191-206

Karger

Access to resources Recommend Favorite

Treatment Efficacy/Safety and Prognostic Factors in Patients with Advanced Biliary Tract Cancer Receiving Gemcitabine Monotherapy: An Analysis of 100 Cases

By  

Oncology, Vol. 79, Iss. 1-2, 2010-11 ,pp. : 39-45

Karger

Access to resources Recommend Favorite